Healthcare & Medical Equipment Suppliers Sector Financials, Performance and Ratios
-
Sector Score
33.4 /100
Rank 23 out of 27 Sectors -
Advance/Decline
76/134
-
No. of Companies210
-
Avg. Market Cap8,852
-
Price to Earning Ratio29.57
-
Price to Earning Growth Ratio2.46
-
Price to Book Ratio6.03
-
Return on Equity36.62
-
Return on Capital Employed-
-
Return on Assets5.82
-
Dividend yield 1 year %0.28 %
-
Net Profit Growth Annual YoY %-1.64 %
-
Net Profit Growth Qtr YoY %11.20 %
-
Net Profit Growth Qtr QoQ %-2.97 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Healthcare & Medical Equipment Suppliers Sector Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Healthcare & Medical Equipment Suppliers Peer comparison
Compare all stocks in Healthcare & Medical Equipment Suppliers industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent Tech |
|
31,823.8
|
112.6
|
L
 -0.6%
H
111.8
113.1
|
L
 -5.1%
H
111.1
118.1
|
L
 -6.5%
H
110.3
124.9
|
L
 -10.5%
H
109.9
127.0
|
L
 1.0%
H
107.1
160.3
|
L
 -11.7%
H
96.4
160.3
|
L
 -14.1%
H
96.4
179.6
|
L
 164.2%
H
42.0
179.6
|
| Amerisource Bergen Corp |
|
-
|
261.1
|
L
 2.1%
H
252.2
261.7
|
L
 2.1%
H
252.2
266.4
|
L
 -18.4%
H
244.8
328.0
|
L
 -27.6%
H
244.8
376.9
|
L
 -10.0%
H
244.8
377.5
|
L
 52.7%
H
163.4
377.5
|
L
 124.1%
H
111.3
377.5
|
L
 254.5%
H
68.4
377.5
|
| Abbott |
|
148,628.9
|
85.3
|
L
 0.5%
H
84.9
86.5
|
L
 -1.9%
H
82.0
87.3
|
L
 -15.0%
H
82.0
102.5
|
L
 -24.3%
H
82.0
116.8
|
L
 -33.6%
H
82.0
139.1
|
L
 -22.8%
H
82.0
141.2
|
L
 -27.9%
H
82.0
142.6
|
L
 126.9%
H
36.8
142.6
|
| Alcon Inc - Registered Shares |
|
31,510.3
|
64.6
|
L
 1.0%
H
64.3
65.0
|
L
 1.1%
H
61.8
65.0
|
L
 -19.2%
H
61.8
82.4
|
L
 -18.4%
H
61.8
87.6
|
L
 -25.9%
H
61.8
92.6
|
L
 -18.6%
H
61.8
101.1
|
L
 -5.5%
H
55.2
101.1
|
L
H
39.4
101.1
|
| Artivion Inc |
|
1,112.1
|
22.9
|
L
 -0.1%
H
22.8
23.3
|
L
 -35.3%
H
19.2
27.3
|
L
 -39.6%
H
19.2
39.7
|
L
 -37.4%
H
19.2
39.7
|
L
 -21.0%
H
19.2
48.3
|
L
 54.1%
H
12.2
48.3
|
L
 -21.0%
H
9.6
48.3
|
L
 95.3%
H
9.6
48.3
|
| Avanos Medical Inc |
|
1,158.0
|
24.7
|
L
 0.1%
H
24.7
24.7
|
L
 -0.2%
H
24.6
24.9
|
L
 0.4%
H
24.6
24.9
|
L
 66.0%
H
12.8
24.9
|
L
 103.5%
H
9.3
24.9
|
L
 7.3%
H
9.3
26.6
|
L
 -38.1%
H
9.3
40.8
|
L
 -11.9%
H
9.3
73.0
|
| Baxter International |
|
8,976.2
|
17.4
|
L
 -2.3%
H
17.3
17.8
|
L
 -0.6%
H
17.1
18.1
|
L
 -1.2%
H
16.2
19.2
|
L
 -12.2%
H
15.7
22.1
|
L
 -42.7%
H
15.7
32.0
|
L
 -59.1%
H
15.7
50.2
|
L
 -79.3%
H
15.7
89.7
|
L
 -61.8%
H
15.7
95.2
|
| Becton, Dickinson and Co. |
|
39,567.6
|
143.6
|
L
 -0.6%
H
143.2
145.5
|
L
 -6.3%
H
142.8
155.3
|
L
 -7.8%
H
142.8
160.0
|
L
 -18.4%
H
142.8
187.4
|
L
 -16.0%
H
142.8
213.1
|
L
 -43.1%
H
142.8
287.3
|
L
 -39.3%
H
142.8
287.3
|
L
 -11.5%
H
142.8
287.3
|
| Butterfly Network Inc (Class A) |
|
1,025.6
|
3.9
|
L
 -4.4%
H
3.9
4.1
|
L
 -7.6%
H
3.9
4.4
|
L
 -11.7%
H
3.9
5.7
|
L
 29.0%
H
2.8
5.7
|
L
 69.7%
H
1.3
5.7
|
L
 116.6%
H
0.7
5.7
|
L
 -60.4%
H
0.7
15.7
|
L
H
0.7
29.1
|
| Bio-Rad Laboratories Inc (Class A) |
|
6,562.7
|
245.2
|
L
 -0.4%
H
242.8
250.1
|
L
 -4.7%
H
236.7
258.8
|
L
 -16.1%
H
236.7
312.9
|
L
 -4.4%
H
236.7
312.9
|
L
 3.4%
H
211.4
343.1
|
L
 -34.2%
H
211.4
431.8
|
L
 -59.2%
H
211.4
832.7
|
L
 71.4%
H
135.9
832.7
|
| Bausch + Lomb Corp |
|
5,718.8
|
16.0
|
L
 -1.4%
H
16.0
16.2
|
L
 0.8%
H
15.7
16.4
|
L
 -4.0%
H
15.3
17.1
|
L
 -5.8%
H
15.1
18.9
|
L
 38.9%
H
11.0
18.9
|
L
 -13.8%
H
10.5
22.0
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
| Boston Scientific |
|
79,757.8
|
53.7
|
L
 0.2%
H
53.5
54.4
|
L
 -5.1%
H
52.8
56.6
|
L
 -15.9%
H
52.8
66.9
|
L
 -28.2%
H
52.8
76.9
|
L
 -47.9%
H
52.8
109.5
|
L
 0.6%
H
48.4
109.5
|
L
 29.1%
H
35.0
109.5
|
L
 140.1%
H
19.7
109.5
|
| Cardinal Health |
|
46,054.2
|
196.6
|
L
 1.2%
H
193.7
196.7
|
L
 6.1%
H
180.5
196.7
|
L
 -8.5%
H
180.5
215
|
L
 -10.9%
H
180.5
233.6
|
L
 32.5%
H
137.8
233.6
|
L
 132.0%
H
80.9
233.6
|
L
 249.0%
H
45.9
233.6
|
L
 157.9%
H
39.1
233.6
|
| Conmed Corp |
|
1,070.4
|
35.6
|
L
 -2.2%
H
35.6
36.7
|
L
 -6.7%
H
35.1
38.7
|
L
 -10.5%
H
35.1
40.6
|
L
 -15.0%
H
33.2
47.1
|
L
 -39.4%
H
33.2
60.8
|
L
 -70.5%
H
33.2
138.5
|
L
 -75.0%
H
33.2
159.1
|
L
 -12.0%
H
33.2
159.1
|
| Cooper Companies |
|
11,818.1
|
60.6
|
L
 0.3%
H
60.3
61.1
|
L
 -0.9%
H
58.9
61.5
|
L
 -15.4%
H
58.9
71.8
|
L
 -27.0%
H
58.9
84.6
|
L
 -24.7%
H
58.9
89.8
|
L
 -37.9%
H
58.9
112.4
|
L
 -37.7%
H
58.9
115.9
|
L
 55.3%
H
39.2
115.9
|
| Danaher |
|
115,763.0
|
163.6
|
L
 -0.6%
H
163.0
166.3
|
L
 -6.9%
H
163.0
175.5
|
L
 -17.7%
H
163.0
200.5
|
L
 -23.1%
H
163.0
212.7
|
L
 -12.9%
H
163.0
242.8
|
L
 -28.1%
H
163.0
281.7
|
L
 -35.5%
H
163.0
334.0
|
L
 121.6%
H
73.4
334.0
|
| Edwards Lifesciences |
|
47,100.4
|
81.8
|
L
 0.6%
H
80.1
81.9
|
L
 -1.2%
H
76.5
83.0
|
L
 4.6%
H
76.5
85.1
|
L
 7.8%
H
76.3
87.3
|
L
 6.6%
H
72.3
87.9
|
L
 -8.3%
H
58.9
96.1
|
L
 -8.6%
H
58.9
131.7
|
L
 138.3%
H
27.0
131.7
|
| Glaukos Corp |
|
8,338.5
|
142.0
|
L
 -0.1%
H
140.9
143.8
|
L
 5.8%
H
130.0
143.8
|
L
 17.8%
H
113
146.8
|
L
 29.7%
H
95.9
146.8
|
L
 55.0%
H
73.2
146.8
|
L
 141.4%
H
54.4
163.7
|
L
 89.9%
H
33.3
163.7
|
L
 485.9%
H
23.1
163.7
|
| Globus Medical Inc (Class A) |
|
10,406.2
|
76.7
|
L
 -0.7%
H
76.1
77.4
|
L
 -9.9%
H
74.5
85.6
|
L
 -19.3%
H
74.5
97.4
|
L
 -13.0%
H
74.5
97.9
|
L
 31.8%
H
51.8
101.4
|
L
 34.9%
H
43.4
101.4
|
L
 6.1%
H
43.4
101.4
|
L
 225.8%
H
19.3
101.4
|
| Haemonetics Corp |
|
2,654.9
|
57.1
|
L
 0.0%
H
56.7
58.2
|
L
 5.1%
H
51
58.7
|
L
 -5.5%
H
51
62.8
|
L
 -1.1%
H
51
66.1
|
L
 -16.8%
H
47.3
87.3
|
L
 -36.1%
H
47.3
98.0
|
L
 2.0%
H
43.5
98.0
|
L
 118.6%
H
26.7
142.1
|
| Herbalife Nutrition Ltd |
|
1,325.9
|
12.8
|
L
 -1.8%
H
12.8
13.2
|
L
 -11.7%
H
12.8
14.7
|
L
 -23.3%
H
12.8
17.5
|
L
 -19.6%
H
12.8
20.4
|
L
 90.6%
H
6.6
20.4
|
L
 -8.8%
H
5.0
20.4
|
L
 -74.3%
H
5.0
55.8
|
L
 -58.1%
H
5.0
61.8
|
| Inspire Medical Systems Inc |
|
1,241.6
|
43.1
|
L
 1.0%
H
42.8
43.9
|
L
 -5.4%
H
41.5
45.7
|
L
 -24.2%
H
41.5
59.0
|
L
 -27.9%
H
41.5
86
|
L
 -72.4%
H
41.5
156.8
|
L
 -85.3%
H
41.5
330
|
L
 -74.8%
H
41.5
330
|
L
H
22.5
330
|
| Integer Holdings Corp |
|
3,025.7
|
89.1
|
L
 -0.8%
H
88.7
90.2
|
L
 1.4%
H
84.3
91.3
|
L
 0.5%
H
77.1
91.3
|
L
 3.7%
H
77.1
100.1
|
L
 -25.5%
H
62
123.8
|
L
 13.7%
H
62
146.4
|
L
 -4.8%
H
50.1
146.4
|
L
 186.0%
H
18.1
146.4
|
| McKesson |
|
91,978.9
|
765.2
|
L
 2.4%
H
751.6
765.5
|
L
 1.4%
H
723.7
772.4
|
L
 -11.3%
H
723.7
873.0
|
L
 -18.1%
H
723.7
999
|
L
 12.2%
H
637
999
|
L
 96.2%
H
373.3
999
|
L
 292.4%
H
184.4
999
|
L
 361.2%
H
106.1
999
|
| Medtronic |
|
98,949.0
|
77.1
|
L
 0.1%
H
76.7
77.4
|
L
 -1.1%
H
74.4
78.3
|
L
 -12.5%
H
74.4
87.9
|
L
 -22.5%
H
74.4
99.0
|
L
 -8.5%
H
74.4
106.3
|
L
 -13.3%
H
68.9
106.3
|
L
 -38.5%
H
68.9
135.9
|
L
 -4.5%
H
68.9
135.9
|
| Mettler-Toledo International |
|
21,120.6
|
1,045.2
|
L
 0.3%
H
1028.0
1045.8
|
L
 -20.8%
H
1023.1
1228.9
|
L
 -22.1%
H
1023.1
1354.1
|
L
 -23.2%
H
1023.1
1411.6
|
L
 -6.5%
H
1023.1
1525.2
|
L
 -24.5%
H
928.5
1546.9
|
L
 -18.0%
H
928.5
1714.8
|
L
 184.1%
H
343.6
1714.8
|
| Envista Holdings Corp |
|
3,837.1
|
23.6
|
L
 -1.2%
H
23.4
24.1
|
L
 -2.9%
H
23.4
25.0
|
L
 -13.9%
H
23.4
29.5
|
L
 -18.6%
H
23.4
29.9
|
L
 31.5%
H
16.4
30.4
|
L
 -28.7%
H
14.2
36.1
|
L
 -47.9%
H
14.2
52.0
|
L
H
10.1
52.0
|
| Owens & Minor Inc |
|
232.8
|
3.0
|
L
H
3.0
3.1
|
L
 -18.7%
H
2.9
4.7
|
L
 -3.5%
H
2.9
4.7
|
L
 35.7%
H
1.9
4.7
|
L
 -56.6%
H
1.8
9.6
|
L
 -83.8%
H
1.8
28.4
|
L
 -90.5%
H
1.8
49.2
|
L
 -91.7%
H
1.8
49.2
|
| Penumbra Inc |
|
12,715.1
|
323.3
|
L
 0.1%
H
323.2
324.1
|
L
 -0.4%
H
321.4
324.9
|
L
 -2.7%
H
321.4
335.2
|
L
 -4.7%
H
321.4
344.5
|
L
 11.9%
H
221.3
362.4
|
L
 0.9%
H
148
362.4
|
L
 34.4%
H
114.9
362.4
|
L
 561.5%
H
45.9
362.4
|
| Koninklijke Philips N.V. (ADR) |
|
24,019.4
|
25.2
|
L
 -1.1%
H
25.2
25.4
|
L
 -7.1%
H
25.2
27.5
|
L
 -13.3%
H
25.1
30.0
|
L
 -19.3%
H
25.1
32.2
|
L
 5.7%
H
22.0
33.4
|
L
 23.2%
H
17.8
33.4
|
L
 -55.2%
H
11.8
57.7
|
L
 3.1%
H
11.8
61.2
|
| Qiagen NV |
|
6,835.1
|
33.1
|
L
 -0.5%
H
33.0
33.3
|
L
 -1.1%
H
32.5
34.0
|
L
 -20.6%
H
32.5
42.3
|
L
 -34.3%
H
32.5
49.9
|
L
 -23.5%
H
32.5
57.8
|
L
 -34.2%
H
32.5
57.8
|
L
 -36.5%
H
32.5
64.7
|
L
 33.4%
H
23.1
65.9
|
| ResMed |
|
29,646.6
|
204.4
|
L
 1.0%
H
203.1
206
|
L
 -1.2%
H
198.6
208.0
|
L
 -11.4%
H
198.6
232.0
|
L
 -19.1%
H
198.6
262.2
|
L
 -17.3%
H
198.6
293.8
|
L
 -12.5%
H
132.2
293.8
|
L
 4.6%
H
132.2
301.3
|
L
 255.8%
H
56.3
301.3
|
| Steris PLC |
|
21,029.2
|
214.4
|
L
 -0.7%
H
213.6
216.7
|
L
 0.3%
H
199.7
216.7
|
L
 -4.6%
H
195.1
227.9
|
L
 -13.4%
H
195.1
255.7
|
L
 -5.8%
H
195.1
269.4
|
L
 1.7%
H
195.1
269.4
|
L
 8.4%
H
159.2
269.4
|
L
 201.3%
H
63.3
269.4
|
| Stevanato Grp Spa |
|
4,796.7
|
17.6
|
L
 -2.3%
H
17.5
17.8
|
L
 -2.6%
H
17.3
18.8
|
L
 19.0%
H
14.6
19.1
|
L
 9.7%
H
12.9
19.1
|
L
 -25.9%
H
12.9
28
|
L
 -36.6%
H
12.9
36.3
|
L
H
12.9
36.3
|
L
H
12.9
36.3
|
| Stryker |
|
118,125.0
|
308.1
|
L
 0.9%
H
306.8
311.1
|
L
 4.7%
H
281
311.1
|
L
 -10.9%
H
281
348.3
|
L
 -15.8%
H
281
389.3
|
L
 -20.2%
H
281
404.9
|
L
 7.9%
H
250.0
406.2
|
L
 21.8%
H
188.8
406.2
|
L
 177.8%
H
106.5
406.2
|
| Smith & Nephew PLC (ADR) |
|
12,651.1
|
29.6
|
L
 -0.3%
H
29.6
29.9
|
L
 -1.4%
H
29.1
30.3
|
L
 -13.7%
H
29.1
34.7
|
L
 -18.1%
H
29.1
37.1
|
L
 6.0%
H
28.2
38.8
|
L
 -6.3%
H
21.5
38.8
|
L
 -31.0%
H
21.5
44.5
|
L
 -12.0%
H
21.5
52.3
|
| Teleflex Incorporated |
|
5,705.5
|
128.9
|
L
 -1.1%
H
128.9
130.9
|
L
 -2.1%
H
127.3
135.7
|
L
 2.9%
H
118.5
139.7
|
L
 24.2%
H
103.1
139.7
|
L
 2.9%
H
100.2
139.7
|
L
 -48.4%
H
100.2
263.0
|
L
 -67.2%
H
100.2
428.4
|
L
 -19.0%
H
100.2
449.4
|
| Thermo Fisher |
|
163,572.9
|
440.2
|
L
 -1.8%
H
438.5
445.0
|
L
 -7.2%
H
438.5
473.5
|
L
 -16.5%
H
438.5
538.4
|
L
 -12.8%
H
438.5
538.4
|
L
 8.4%
H
385.5
644.0
|
L
 -16.1%
H
385.5
644.0
|
L
 -4.1%
H
385.5
672.3
|
L
 197.6%
H
139.1
672.3
|
| Waters |
|
32,499.5
|
331
|
L
 -0.7%
H
328.2
332.1
|
L
 -5.6%
H
328.2
357.5
|
L
 0.0%
H
287.2
357.5
|
L
 2.4%
H
282.8
357.5
|
L
 -4.2%
H
275.1
414.2
|
L
 22.1%
H
231.9
423.6
|
L
 6.0%
H
231.9
428.2
|
L
 145.6%
H
131.4
428.2
|
| West Pharma Services |
|
21,259.3
|
300.9
|
L
 0.2%
H
296.8
302.8
|
L
 -6.6%
H
295.9
330.9
|
L
 12.3%
H
264.5
330.9
|
L
 20.1%
H
228.4
330.9
|
L
 45.6%
H
202.8
330.9
|
L
 -16.4%
H
187.4
415.7
|
L
 -9.7%
H
187.4
475.4
|
L
 319.9%
H
70.2
475.4
|
| Zimmer Biomet Holdings |
|
16,063.2
|
83.0
|
L
 0.5%
H
83.0
84.0
|
L
 -0.4%
H
79.1
85.2
|
L
 -14.0%
H
79.1
96.7
|
L
 -13.9%
H
79.1
101.5
|
L
 -12.9%
H
79.1
108.3
|
L
 -39.3%
H
79.1
147.5
|
L
 -47.3%
H
79.1
160.0
|
L
 -24.9%
H
70.0
169.7
|
| BioRad Laboratories Inc |
|
7,485.1
|
260
|
L
H
244.5
260
|
L
 -0.5%
H
244.5
260
|
L
 -6.1%
H
244.5
299.5
|
L
 1.2%
H
244.5
299.5
|
L
 4.0%
H
244.5
321.1
|
L
 -21.7%
H
225.3
373.4
|
L
 -21.7%
H
225.3
373.4
|
L
 -21.7%
H
225.3
373.4
|
| Haleon PLC (ADR) |
|
39,501.5
|
8.9
|
L
H
8.9
9.0
|
L
 -4.2%
H
8.9
9.2
|
L
 -8.1%
H
8.9
9.8
|
L
 -20.5%
H
8.9
11.3
|
L
 -14.3%
H
8.7
11.4
|
L
 2.1%
H
7.7
11.4
|
L
H
5.6
11.4
|
L
H
5.6
11.4
|
| Revvity |
|
10,559.1
|
94.7
|
L
 -1.8%
H
93.8
95.1
|
L
 -4.3%
H
93.8
103
|
L
 1.2%
H
81.2
103
|
L
 -1.4%
H
81.2
103
|
L
 4.0%
H
81.2
118.3
|
L
 -18.6%
H
79.5
132.0
|
L
 -34.1%
H
79.5
203.2
|
L
 73.8%
H
45.4
203.2
|
| Aethlon Medical Inc |
|
3.4
|
2.1
|
L
H
2.1
2.2
|
L
 -7.0%
H
2.1
2.5
|
L
 -7.4%
H
2.1
2.5
|
L
 9.2%
H
1.4
2.5
|
L
 -93.4%
H
1.4
34.1
|
L
 -99.2%
H
1.4
400
|
L
 -99.8%
H
1.4
9992
|
L
 -100.0%
H
1.4
109078.8
|
| Ainos Inc |
|
12.7
|
1.7
|
L
H
1.7
1.8
|
L
 -1.2%
H
1.7
1.8
|
L
 4.2%
H
1.5
2.0
|
L
 13.2%
H
1.3
2.0
|
L
 -34.9%
H
1.3
4.5
|
L
 -90.4%
H
1.3
30.5
|
L
 -99.4%
H
1.3
1781.3
|
L
 352.6%
H
0.1
1781.3
|
| Airsculpt Tech Inc |
|
321.0
|
4.6
|
L
 -4.0%
H
4.4
4.7
|
L
 31.5%
H
3.4
4.9
|
L
 73.7%
H
2.3
4.9
|
L
 140.7%
H
1.5
4.9
|
L
 34.2%
H
1.5
12
|
L
 -32.3%
H
1.5
12
|
L
H
1.5
18.5
|
L
H
1.5
18.5
|
| Align Tech |
|
11,305.6
|
157.9
|
L
 -1.7%
H
157.7
161
|
L
 -6.3%
H
157.7
169.7
|
L
 -14.5%
H
157.7
200.4
|
L
 -15.5%
H
157.7
200.4
|
L
 -15.9%
H
122
208.3
|
L
 -46.3%
H
122
413.2
|
L
 -72.3%
H
122
737.5
|
L
 107.5%
H
74.9
737.5
|
| Angiodynamic Inc |
|
452.4
|
11.0
|
L
 -0.7%
H
10.9
11.1
|
L
 -2.8%
H
10.7
11.4
|
L
 4.6%
H
10.3
11.4
|
L
 -0.2%
H
9.4
12.0
|
L
 17.9%
H
8.4
14.0
|
L
 17.6%
H
5.3
14.0
|
L
 -52.3%
H
5.3
32
|
L
 -8.1%
H
5.3
32
|
| Anika Therapeutics Inc |
|
197.3
|
14.8
|
L
 -3.3%
H
14.8
15.4
|
L
 -2.1%
H
14.2
15.7
|
L
 -3.1%
H
11.9
16.2
|
L
 45.3%
H
10.2
16.2
|
L
 31.0%
H
7.9
16.2
|
L
 -41.1%
H
7.9
29.1
|
L
 -66.0%
H
7.9
48.4
|
L
 -66.1%
H
7.9
75.7
|
| Apyx Medical Corp |
|
178.8
|
4.3
|
L
 -2.1%
H
4.2
4.4
|
L
 19.9%
H
3.4
4.4
|
L
 11.2%
H
2.8
4.4
|
L
 14.8%
H
2.8
4.4
|
L
 202.8%
H
1.3
4.5
|
L
 -20.3%
H
0.8
8.0
|
L
 -56.3%
H
0.8
17.5
|
L
 145.4%
H
0.8
17.5
|
| Accuray Inc |
|
32.1
|
0.3
|
L
 -3.6%
H
0.3
0.3
|
L
 -6.9%
H
0.3
0.4
|
L
 -32.5%
H
0.3
0.5
|
L
 -50.9%
H
0.3
0.6
|
L
 -83.0%
H
0.3
2.1
|
L
 -92.4%
H
0.3
4.3
|
L
 -93.8%
H
0.3
5.9
|
L
 -94.8%
H
0.3
6.4
|
| Alphatec Holdings Inc |
|
1,182.6
|
7.7
|
L
 1.6%
H
7.5
7.8
|
L
 -0.8%
H
6.8
8
|
L
 -33.3%
H
6.8
11.8
|
L
 -42.4%
H
6.8
14.4
|
L
 -39.6%
H
6.8
23.3
|
L
 -50.7%
H
4.9
23.3
|
L
 -48.1%
H
4.9
23.3
|
L
 228.6%
H
1.2
23.3
|
| Atricure Inc |
|
1,444.8
|
28.5
|
L
 1.4%
H
28.2
29.3
|
L
 2.6%
H
25.5
29.3
|
L
 -3.0%
H
25.5
30.1
|
L
 -12.6%
H
25.5
33.7
|
L
 -11.5%
H
25.5
43.2
|
L
 -40.7%
H
18.9
59.6
|
L
 -60.4%
H
18.9
89.2
|
L
 110.2%
H
13.5
89.2
|
| Axogen Inc |
|
2,147.9
|
40.4
|
L
 -1.4%
H
40.4
41.0
|
L
 -7.0%
H
39.5
43.5
|
L
 17.2%
H
32.9
45.8
|
L
 21.6%
H
27.5
45.8
|
L
 241.7%
H
9.2
45.8
|
L
 338.1%
H
3.5
45.8
|
L
 88.1%
H
3.5
45.8
|
L
 659.2%
H
3.5
56.9
|
| Bone Biologics Corp |
|
2.3
|
1.3
|
L
 1.6%
H
1.3
1.3
|
L
H
1.3
1.4
|
L
 2.4%
H
1.3
1.4
|
L
 8.4%
H
1.1
1.4
|
L
 -71.0%
H
1.1
6.8
|
L
 -99.5%
H
1.1
432.2
|
L
 -100.0%
H
1.1
10255.5
|
L
 -100.0%
H
1.1
169920
|
| BioAffinity Tech Inc |
|
8.8
|
1.9
|
L
 -3.0%
H
1.9
2.0
|
L
 -9.0%
H
1.9
2.2
|
L
 -31.3%
H
1.8
3.0
|
L
 85.6%
H
0.9
5.4
|
L
 -71.4%
H
0.7
15
|
L
 -96.5%
H
0.7
108.6
|
L
H
0.7
466.5
|
L
H
0.7
466.5
|
| Bluejay Diagnostics Inc |
|
1.8
|
1.7
|
L
 -1.7%
H
1.7
1.7
|
L
 -6.0%
H
1.7
1.9
|
L
 -8.1%
H
1.7
2.1
|
L
 -36.0%
H
1.7
2.8
|
L
 -75%
H
1.7
16.7
|
L
 -100.0%
H
1.7
22368
|
L
H
1.7
200000
|
L
H
1.7
200000
|
| Biolife Soln Inc |
|
1,014.8
|
20.8
|
L
 -1.4%
H
20.5
20.9
|
L
 -10.2%
H
20.5
23.1
|
L
 2.5%
H
19.7
23.2
|
L
 -6.6%
H
17.9
25.3
|
L
 -5.8%
H
17.9
29.6
|
L
 10.5%
H
8.9
29.6
|
L
 -30.2%
H
8.9
60.7
|
L
 1136.3%
H
1.4
60.7
|
| Biomerica Inc |
|
7.5
|
2.4
|
L
 0.4%
H
2.4
2.4
|
L
 10%
H
2.2
2.4
|
L
 15.2%
H
2.1
2.4
|
L
 5.7%
H
1.9
2.4
|
L
 -30.9%
H
1.9
4.6
|
L
 116.1%
H
0.2
4.9
|
L
 -31.8%
H
0.2
7.4
|
L
 61.3%
H
0.2
23.4
|
| Bruker Corp |
|
6,597.5
|
43.3
|
L
 -1.9%
H
43.1
44.1
|
L
 -0.9%
H
42.1
45.2
|
L
 8.6%
H
33.8
45.2
|
L
 18.7%
H
32.4
45.2
|
L
 17.6%
H
28.5
56.2
|
L
 -41.2%
H
28.5
94.9
|
L
 -36.8%
H
28.5
94.9
|
L
 62.3%
H
19.6
94.9
|
| BioRestorative Therapies Inc |
|
4.8
|
0.2
|
L
H
0.2
0.2
|
L
 -13.6%
H
0.2
0.2
|
L
 -24%
H
0.2
0.3
|
L
 -32.1%
H
0.2
0.3
|
L
 -88.9%
H
0.2
2.0
|
L
 -96.2%
H
0.2
7.1
|
L
 -99.4%
H
0.2
40
|
L
 -100.0%
H
0.2
20040
|
| Biosig Tech Inc |
|
88.9
|
0.9
|
L
 -5.2%
H
0.9
0.9
|
L
 -6.2%
H
0.8
1.0
|
L
 -11.7%
H
0.7
1.3
|
L
 -62.2%
H
0.7
2.7
|
L
 -66.5%
H
0.7
14.1
|
L
 -31.1%
H
0.1
14.1
|
L
 -72.7%
H
0.1
14.1
|
L
 -80.6%
H
0.1
14.1
|
| Bioventus Inc (Class A) |
|
712.7
|
10.5
|
L
 -0.9%
H
10.5
10.8
|
L
 -1.2%
H
10.0
10.9
|
L
 6.2%
H
9.5
11.3
|
L
 27.2%
H
8.1
11.3
|
L
 64.9%
H
5.8
11.3
|
L
 755.3%
H
1.1
14.4
|
L
 -33.6%
H
0.8
19.9
|
L
H
0.8
19.9
|
| Brainsway Ltd (ADR) |
|
627.8
|
15.7
|
L
 -3.9%
H
15.5
15.9
|
L
 -6.2%
H
15.4
17.4
|
L
 4.7%
H
15.2
17.4
|
L
 172.7%
H
5.6
17.4
|
L
 510.1%
H
2.5
17.4
|
L
 4255.6%
H
0.4
17.4
|
L
 609.5%
H
0.3
17.4
|
L
H
0.3
17.4
|
| Cardio Diagnostics Holdings Inc |
|
5.0
|
1.7
|
L
H
1.6
1.7
|
L
 -7.2%
H
1.6
2.0
|
L
 -12.5%
H
1.6
2.4
|
L
 32.3%
H
1.2
7.9
|
L
 -62.9%
H
1.0
7.9
|
L
 -96.7%
H
1.0
106.8
|
L
H
1.0
307.5
|
L
H
1.0
307.5
|
| Caredx Inc |
|
1,037.3
|
20.1
|
L
 -2%
H
19.9
20.4
|
L
 -6.3%
H
19.9
22.3
|
L
 13.9%
H
17.0
23.2
|
L
 2.3%
H
15.6
23.2
|
L
 25.3%
H
11.0
23.2
|
L
 149.4%
H
4.8
34.8
|
L
 -69.6%
H
4.8
96.9
|
L
 378.1%
H
0.8
99.8
|
| Celcuity Inc |
|
6,594.6
|
136.4
|
L
 1.3%
H
126.4
137.7
|
L
 4.4%
H
121.7
138
|
L
 12.9%
H
106.6
151.0
|
L
 30.5%
H
100.0
151.0
|
L
 1156.3%
H
9.5
151.0
|
L
 1313.8%
H
7.6
151.0
|
L
 407.0%
H
4.8
151.0
|
L
H
4.0
151.0
|
| Creative Medical Tech Holdings Inc |
|
8.1
|
2.2
|
L
 -1.8%
H
2.2
2.2
|
L
 -3.9%
H
2.1
2.4
|
L
 -3.9%
H
2.1
2.5
|
L
 18.3%
H
1.8
2.5
|
L
 7.8%
H
1.5
6.3
|
L
 -66.7%
H
1.5
10.3
|
L
 -98.5%
H
1.5
215
|
L
 -100.0%
H
1.5
525000
|
| Cerus Corp |
|
478.9
|
2.4
|
L
 -4.8%
H
2.4
2.5
|
L
 -8.4%
H
2.4
2.7
|
L
 18.9%
H
1.9
3.2
|
L
 6.7%
H
1.6
3.2
|
L
 91.2%
H
1.2
3.2
|
L
 27.1%
H
1.1
3.2
|
L
 -58.4%
H
1.1
8.1
|
L
 -55.0%
H
1.1
8.9
|
| Check-Cap Ltd |
|
12.6
|
1.8
|
L
H
1.7
1.8
|
L
 20.1%
H
1.4
2.1
|
L
 1.7%
H
1.3
2.1
|
L
 -2.7%
H
1.3
2.2
|
L
 84.5%
H
0.6
3.9
|
L
 25.2%
H
0.6
4.6
|
L
 -93.3%
H
0.6
38.2
|
L
 -100.0%
H
0.6
820.8
|
| CollPlant biotech Ltd - Ordinary Shares New |
|
6.2
|
0.4
|
L
 2.4%
H
0.4
0.4
|
L
 10.3%
H
0.4
0.4
|
L
 48.3%
H
0.3
0.5
|
L
 -40.3%
H
0.3
0.9
|
L
 -73.8%
H
0.3
5.0
|
L
 -93.8%
H
0.3
8.9
|
L
 -96.9%
H
0.3
23.5
|
L
 -96.8%
H
0.3
24.3
|
| ClearPoint Neuro Inc |
|
360.8
|
12.0
|
L
 -5.8%
H
11.9
12.6
|
L
 3%
H
11.3
13.6
|
L
 15.9%
H
10.2
13.6
|
L
 -11.2%
H
8.3
15.3
|
L
 -3.2%
H
8.3
30.1
|
L
 34.4%
H
4.1
30.1
|
L
 -33.5%
H
4.1
30.1
|
L
 -14.1%
H
1.3
31.3
|
| Cardiff Oncology Inc |
|
113.5
|
1.7
|
L
 -4.1%
H
1.7
1.7
|
L
 3.8%
H
1.6
1.7
|
L
 1.8%
H
1.6
1.8
|
L
 3.8%
H
1.5
2.1
|
L
 -37.8%
H
1.5
4.6
|
L
 -1.8%
H
0.9
6.4
|
L
 -80.6%
H
0.9
8.9
|
L
 -99.4%
H
0.7
430.6
|
| Castle Biosciences Inc |
|
568.1
|
18.7
|
L
 -0.8%
H
18.6
19.1
|
L
 -2.7%
H
17.7
20.0
|
L
 -23.1%
H
17.7
25.7
|
L
 -43.5%
H
17.7
34.4
|
L
 14.8%
H
14.6
44.3
|
L
 -18.1%
H
9.3
44.3
|
L
 -66.1%
H
9.3
78.9
|
L
H
9.3
107.7
|
| Cytek BioSciences Inc |
|
436.5
|
3.4
|
L
 0.6%
H
3.3
3.4
|
L
 -31.3%
H
3.3
4.8
|
L
 -26.8%
H
3.3
5.0
|
L
 -20.3%
H
3.3
5.0
|
L
 23.8%
H
2.4
6.2
|
L
 -54.9%
H
2.4
9.9
|
L
H
2.4
28.7
|
L
H
2.4
28.7
|
| Cytosorbents Corp |
|
32.7
|
0.5
|
L
 -3.7%
H
0.5
0.5
|
L
 -14.8%
H
0.5
0.6
|
L
 -11.9%
H
0.5
0.7
|
L
 -18.8%
H
0.5
0.8
|
L
 -35.8%
H
0.5
1.4
|
L
 -84.3%
H
0.5
4.3
|
L
 -93.7%
H
0.5
9.8
|
L
 -87.2%
H
0.5
15.0
|
| Citius Pharma Inc |
|
19.5
|
0.7
|
L
 -1.4%
H
0.7
0.7
|
L
 9.2%
H
0.6
0.8
|
L
 -13.4%
H
0.6
1.0
|
L
 -6.6%
H
0.6
1.1
|
L
 -24.5%
H
0.6
2.5
|
L
 -98.0%
H
0.1
35.5
|
L
 -98.6%
H
0.1
114
|
L
 -99.9%
H
0.1
513.8
|
| CVRx Inc |
|
150.9
|
5.7
|
L
 -0.5%
H
5.7
5.9
|
L
 -22.0%
H
5
7.2
|
L
 -26.0%
H
5
8.2
|
L
 15.4%
H
4.4
9.8
|
L
 7.9%
H
4.4
11.3
|
L
 -53.5%
H
4.3
33.1
|
L
H
4.3
33.1
|
L
H
4.3
33.1
|
| Delcath Systems Inc |
|
387.3
|
11.2
|
L
 -2.1%
H
11
11.3
|
L
 -0.2%
H
10.8
11.7
|
L
 3.1%
H
10.1
12.3
|
L
 20.5%
H
8.5
12.3
|
L
 -27.5%
H
8.1
18.2
|
L
 87%
H
2.3
18.2
|
L
 10%
H
2.3
18.2
|
L
 -100.0%
H
2.3
838880000
|
| Alpha Tau Medical Ltd |
|
936.4
|
10.6
|
L
 2.2%
H
10.2
10.8
|
L
 35.5%
H
7.7
10.8
|
L
 35.9%
H
7.2
10.8
|
L
 47.6%
H
6.1
10.8
|
L
 276.0%
H
2.8
10.8
|
L
 174.9%
H
1.8
10.8
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
| DexCom |
|
23,735.0
|
61.5
|
L
 6.4%
H
59.5
61.6
|
L
 1.0%
H
57.7
61.6
|
L
 -2.3%
H
56.7
65.3
|
L
 -12.2%
H
56.7
74.5
|
L
 -28.9%
H
54.1
90.0
|
L
 -49.5%
H
54.1
142
|
L
 -26.2%
H
54.1
164.9
|
L
 305.7%
H
10.7
164.9
|
| Daxor Corp |
|
61.2
|
10.5
|
L
H
10.5
10.5
|
L
 8.7%
H
9.8
12.2
|
L
 11.9%
H
9.1
12.3
|
L
 -15.3%
H
8.6
12.8
|
L
 43.8%
H
7.4
14.8
|
L
 -16%
H
6.6
14.8
|
L
 10.6%
H
6.6
15.5
|
L
 30.1%
H
3.4
24.1
|
| ElectroCore Inc |
|
52.7
|
6.4
|
L
 -1.2%
H
6.3
6.4
|
L
 1.3%
H
6.1
6.9
|
L
 -3.1%
H
5.9
7.3
|
L
 16.9%
H
5.4
8.2
|
L
 38.0%
H
4.2
8.6
|
L
 -2.5%
H
3.8
19.5
|
L
 -73.4%
H
2.9
27.8
|
L
H
2.9
303.8
|
| ChronoScale Corp |
|
2,675.8
|
18.7
|
L
 4.4%
H
17.5
19.0
|
L
 24.7%
H
13.0
20.3
|
L
 87%
H
9.8
20.3
|
L
 89.5%
H
7.9
20.3
|
L
 -81.6%
H
2.7
146.3
|
L
 -94.7%
H
2.7
704.0
|
L
 -98.4%
H
2.7
1372.5
|
L
 -99.9%
H
2.7
23591.3
|
| Embecta Corp |
|
186.3
|
3.1
|
L
H
3.1
3.2
|
L
 -12.8%
H
3.1
3.8
|
L
 -66.8%
H
3.1
9.9
|
L
 -69.1%
H
3.1
10.9
|
L
 -72.9%
H
3.1
15.6
|
L
 -89.8%
H
3.1
30.8
|
L
H
3.1
63
|
L
H
3.1
63
|
| Establishment Labs Holdings Inc |
|
1,992.1
|
67.7
|
L
 -3.0%
H
66.7
68.6
|
L
 -6.0%
H
65.0
72.9
|
L
 1.8%
H
61.1
76.5
|
L
 -9.3%
H
53.2
83.3
|
L
 85.7%
H
33.4
83.3
|
L
 1.6%
H
17
83.3
|
L
 -2.7%
H
17
93.8
|
L
H
7.6
93.8
|
| EDAP TMS S.A. (ADR) |
|
157.4
|
4.2
|
L
 1.7%
H
4.1
4.2
|
L
 1.0%
H
3.9
4.4
|
L
 24.6%
H
3.1
4.4
|
L
 -10.1%
H
3.1
4.9
|
L
 94.4%
H
1.2
5.1
|
L
 -62.3%
H
1.2
12.1
|
L
 -29.6%
H
1.2
12.7
|
L
 22.4%
H
1.2
12.7
|
| GlucoTrack Inc |
|
2.5
|
0.7
|
L
H
0.7
0.7
|
L
 -22.1%
H
0.6
0.9
|
L
 -9.5%
H
0.6
1.3
|
L
 -59.4%
H
0.6
1.7
|
L
 -92.6%
H
0.6
15.9
|
L
 -100.0%
H
0.6
5940
|
L
 -100.0%
H
0.6
46800
|
L
 -100.0%
H
0.6
468000
|
| GE HealthCare Tech |
|
28,075.9
|
61.7
|
L
 -1.5%
H
61.6
62.6
|
L
 0.6%
H
61.0
64.4
|
L
 -17.3%
H
58.8
76.0
|
L
 -23.2%
H
58.8
87.1
|
L
 -15.3%
H
58.8
89.8
|
L
 -17.6%
H
57.7
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
| Harvard Bioscience Inc |
|
24.0
|
5.3
|
L
 -3.6%
H
5.3
5.4
|
L
 -21.7%
H
5.3
7.2
|
L
 8.4%
H
4.9
7.5
|
L
 -4.1%
H
4
7.5
|
L
 53.8%
H
2.8
9.5
|
L
 -90.5%
H
2.8
62
|
L
 -92.4%
H
2.8
87.5
|
L
 -82.2%
H
2.8
87.5
|
| Heart Test Laboratories Inc |
|
6.0
|
1.9
|
L
 -1.1%
H
1.9
1.9
|
L
 -2.6%
H
1.8
2.1
|
L
 -4.1%
H
1.8
2.2
|
L
 -37%
H
1.8
3.1
|
L
 -43.4%
H
1.8
6.5
|
L
 -98.3%
H
1.8
128
|
L
H
1.8
600
|
L
H
1.8
600
|
| Helius Medical Tech Inc (Class A) |
|
126.2
|
2.3
|
L
 -3.8%
H
2.3
2.3
|
L
 7.0%
H
2.1
2.4
|
L
 16.2%
H
1.9
2.4
|
L
 4.1%
H
1.6
2.4
|
L
 -98.9%
H
1.6
258.5
|
L
 -100.0%
H
1.6
10836.4
|
L
 -100.0%
H
1.6
647250
|
L
 -100.0%
H
1.6
27168750
|
| Henry Schein |
|
8,180.4
|
71.8
|
L
 -1.1%
H
71.5
72.9
|
L
 1.9%
H
68.7
72.9
|
L
 -7.0%
H
68.7
81.1
|
L
 -8.2%
H
68.7
89.3
|
L
 2.5%
H
61.9
89.3
|
L
 -6.0%
H
60.0
89.3
|
L
 -11.0%
H
60.0
92.7
|
L
 6.5%
H
41.9
92.7
|
| Hyperfine Inc (Class A) |
|
153.9
|
1.6
|
L
 -3.1%
H
1.6
1.6
|
L
 -7.7%
H
1.6
1.8
|
L
 24%
H
1.2
1.9
|
L
 39.6%
H
1.0
1.9
|
L
 154.1%
H
0.5
2.2
|
L
 8.4%
H
0.5
3.3
|
L
 -84.3%
H
0.5
16.6
|
L
H
0.5
16.6
|
| Integra Lifesciences Holdings Corp |
|
1,091.5
|
14.0
|
L
 -3.2%
H
14.0
14.3
|
L
 3.5%
H
12.9
15.1
|
L
 26.9%
H
10.0
15.1
|
L
 23.9%
H
8.7
15.1
|
L
 8.6%
H
8.7
16.5
|
L
 -71.4%
H
8.7
50.8
|
L
 -80.2%
H
8.7
76.7
|
L
 -60.5%
H
8.7
77.4
|
| Icecure Medical Ltd |
|
19.5
|
0.2
|
L
H
0.2
0.2
|
L
 -4%
H
0.2
0.3
|
L
 -33.3%
H
0.2
0.4
|
L
 -57.9%
H
0.2
0.7
|
L
 -76%
H
0.2
1.4
|
L
 -81.0%
H
0.2
1.7
|
L
 -98.1%
H
0.2
14
|
L
 -79.1%
H
0.2
16
|
| SeaStar Medical Holding Corp |
|
16.5
|
4.1
|
L
 -1.9%
H
4.1
4.2
|
L
 -15.2%
H
4.0
5.0
|
L
 9.9%
H
3.7
5.1
|
L
 71.7%
H
2.1
5.1
|
L
 -96.7%
H
2.1
134
|
L
 -99.8%
H
2.1
4292.3
|
L
 -100.0%
H
2.1
55000
|
L
H
2.1
55000
|
| ICU Medical Inc |
|
3,060.7
|
122.5
|
L
 -0.4%
H
120.1
123.7
|
L
 -0.5%
H
120.1
132.7
|
L
 -4.2%
H
113.4
132.7
|
L
 -15.5%
H
113.4
159.9
|
L
 -9.9%
H
107
160.3
|
L
 -39.0%
H
78.4
203.4
|
L
 -38.5%
H
78.4
282
|
L
 22.6%
H
78.4
321.7
|
| Idexx Laboratories |
|
42,136.9
|
534.2
|
L
 0.3%
H
532.5
541.0
|
L
 -6.7%
H
523.4
572.2
|
L
 -8.5%
H
523.4
594.5
|
L
 -15.1%
H
523.4
666.1
|
L
 4.9%
H
496.6
770.0
|
L
 9.6%
H
356.3
770.0
|
L
 0.8%
H
317.1
770.0
|
L
 516.3%
H
86.0
770.0
|
| Inspira Tech Oxy B.H.N. Ltd |
|
17.0
|
0.4
|
L
 -2.5%
H
0.4
0.4
|
L
 -13.3%
H
0.4
0.5
|
L
 -18.8%
H
0.4
0.7
|
L
 -33.9%
H
0.3
0.7
|
L
 -27.8%
H
0.3
1.7
|
L
 -70.9%
H
0.3
2.5
|
L
H
0.3
9.6
|
L
H
0.3
9.6
|
| Intercure Ltd |
|
44.8
|
0.8
|
L
H
0.8
0.8
|
L
 -2.4%
H
0.8
0.9
|
L
 7.9%
H
0.7
0.9
|
L
 -8.9%
H
0.7
0.9
|
L
 -46.1%
H
0.7
1.8
|
L
 -67.2%
H
0.7
3.7
|
L
 -87.1%
H
0.7
8.8
|
L
H
0.7
19.4
|
| Inogen Inc |
|
177.3
|
6.6
|
L
 -3.7%
H
6.5
6.7
|
L
 -8.9%
H
6.4
7.4
|
L
 3.3%
H
6.1
7.7
|
L
 13.7%
H
5.3
7.7
|
L
 11.4%
H
5.3
9.1
|
L
 -39.6%
H
4.1
13.3
|
L
 -90.1%
H
4.1
82.4
|
L
 -85.0%
H
4.1
287.8
|
| Inmode Ltd |
|
852.5
|
14.0
|
L
 -0.2%
H
14.0
14.2
|
L
 0.7%
H
13.6
14.2
|
L
 -0.9%
H
13.3
14.8
|
L
 -2.0%
H
12.7
15.3
|
L
 -3.8%
H
12.7
16.7
|
L
 -58.2%
H
12.7
48.3
|
L
 -62.1%
H
12.7
99.3
|
L
H
6.5
99.3
|
| NAYA Biosciences |
|
2.6
|
1.6
|
L
 1.9%
H
1.6
1.6
|
L
 -12.6%
H
1.6
2.0
|
L
 -27.1%
H
1.6
2.4
|
L
 -70%
H
1.6
5.3
|
L
 -99.3%
H
1.6
264
|
L
 -100.0%
H
1.6
12384
|
L
 -100.0%
H
1.6
156314.9
|
L
 -100.0%
H
1.6
709632
|
| IRIDEX Corp |
|
17.7
|
1.0
|
L
 1.0%
H
1.0
1.0
|
L
 -1.0%
H
1.0
1.1
|
L
 -1.0%
H
1.0
1.1
|
L
 -26.1%
H
1.0
1.5
|
L
 2%
H
0.9
1.7
|
L
 -54.7%
H
0.8
3.7
|
L
 -86.4%
H
0.8
9.5
|
L
 -91.4%
H
0.8
16.6
|
| Iradimed Corp |
|
1,112.4
|
87.0
|
L
 0.2%
H
86.0
88.3
|
L
 0.3%
H
83.1
88.3
|
L
 -7.0%
H
77.0
94.9
|
L
 -12.8%
H
77.0
107
|
L
 67.6%
H
50.9
107.9
|
L
 88.2%
H
36.1
107.9
|
L
 195.9%
H
26
107.9
|
L
 398.1%
H
7.9
107.9
|
| iRhythm Tech Inc |
|
3,747.6
|
114.0
|
L
 -0.1%
H
114
116.6
|
L
 -8.7%
H
112.5
125.1
|
L
 -7.5%
H
112.5
130.0
|
L
 -20.9%
H
112.3
164.7
|
L
 -18.8%
H
112.3
212
|
L
 -9.7%
H
55.9
212
|
L
 40.3%
H
41.7
212
|
L
H
22.2
286.2
|
| Intuitive Surgical |
|
151,989.0
|
429.2
|
L
 0.3%
H
426.5
432.0
|
L
 -5.4%
H
417.7
454.3
|
L
 -8.2%
H
417.7
491.2
|
L
 -11.7%
H
417.7
511.9
|
L
 -24.2%
H
417.7
603.9
|
L
 40.6%
H
254.9
616
|
L
 54.5%
H
180.1
616
|
L
 514.2%
H
67.9
616
|
| Jowell Global Ltd |
|
5.3
|
2.2
|
L
 -5.2%
H
2.2
2.3
|
L
 -13.3%
H
2.2
2.5
|
L
 -7.5%
H
2.2
2.8
|
L
 -1.3%
H
1.9
2.8
|
L
 -3.9%
H
1.5
3.0
|
L
 -44.8%
H
1
5.6
|
L
 -98.2%
H
1
412.5
|
L
H
1
412.5
|
| Kewaunee Scientific Corp |
|
110.9
|
38.7
|
L
H
38.0
39.1
|
L
 6.0%
H
35.4
39.1
|
L
 12.4%
H
34.4
39.1
|
L
 -2.7%
H
33.7
43.4
|
L
 4.4%
H
33.7
60.9
|
L
 135.1%
H
14.6
71.3
|
L
 225.0%
H
11.4
71.3
|
L
 133.0%
H
7.0
71.3
|
| OrthoPediatrics corp |
|
451.5
|
17.6
|
L
 -1.8%
H
17.4
17.8
|
L
 0.1%
H
16.9
18.6
|
L
 -1.6%
H
14.4
18.6
|
L
 4.1%
H
14.4
20.2
|
L
 -23.1%
H
14.4
23.7
|
L
 -61.1%
H
14.4
48.5
|
L
 -68.6%
H
14.4
73.9
|
L
H
14
73.9
|
| KORU Medical Systems Inc |
|
180.5
|
3.9
|
L
 -1.3%
H
3.9
4
|
L
 -11.5%
H
3.8
4.4
|
L
 -8.6%
H
3.8
4.7
|
L
 -15.9%
H
3.8
5.1
|
L
 30.6%
H
2.6
6.6
|
L
 -0.8%
H
1.9
6.6
|
L
 -4.1%
H
1.8
6.6
|
L
 1055.9%
H
0.3
12.8
|
| Standard BioTools Inc |
|
386.5
|
1.0
|
L
 -1%
H
1.0
1
|
L
 -1%
H
1.0
1.0
|
L
 12.5%
H
0.9
1.0
|
L
 -11.6%
H
0.9
1.3
|
L
 -7.5%
H
0.9
1.7
|
L
 -44.1%
H
0.9
3.2
|
L
 -81.9%
H
0.9
7.5
|
L
 -89.3%
H
0.9
14.9
|
| LivaNova PLC |
|
3,900.3
|
71
|
L
 -0.9%
H
69.6
71.2
|
L
 0.1%
H
69.2
73.3
|
L
 9.3%
H
56.4
73.3
|
L
 7.9%
H
56.4
73.3
|
L
 63.0%
H
41.0
73.3
|
L
 50.9%
H
32.5
73.3
|
L
 -15.6%
H
32.5
93.9
|
L
 47.0%
H
32.5
131.5
|
| Lemaitre Vascular Inc |
|
2,269.1
|
99.3
|
L
 -0.2%
H
98.5
99.7
|
L
 -8.0%
H
95.5
109.7
|
L
 -15.4%
H
95.5
117.4
|
L
 13.3%
H
85.8
118.0
|
L
 19.6%
H
78.4
118.0
|
L
 52.1%
H
44.3
118.0
|
L
 101.9%
H
38.3
118.0
|
L
 542.3%
H
13.5
118.0
|
| LENSAR Inc |
|
69.5
|
5.7
|
L
 -1.5%
H
5.7
5.7
|
L
 9.8%
H
5.2
6.1
|
L
 -5.0%
H
5.1
6.3
|
L
 -53.1%
H
5.1
12.3
|
L
 -59.5%
H
5.1
14.3
|
L
 126.0%
H
1.8
17.3
|
L
 -28.2%
H
1.8
17.3
|
L
H
1.8
17.3
|
| Lantheus Holdings Inc |
|
6,186.4
|
95.0
|
L
 -1.7%
H
94
96.7
|
L
 4.4%
H
91.7
98.3
|
L
 14.8%
H
80
98.3
|
L
 37.0%
H
69.4
98.3
|
L
 20.6%
H
47.3
98.3
|
L
 -4.6%
H
47.3
126.9
|
L
 349.9%
H
19.3
126.9
|
L
 4161.0%
H
1.9
126.9
|
| Lucid Diagnostics Inc |
|
186.9
|
1.0
|
L
 -3.9%
H
1.0
1.0
|
L
 -6.7%
H
1.0
1.1
|
L
 -27.4%
H
1.0
1.4
|
L
 -26.3%
H
1.0
1.5
|
L
 -23.4%
H
1.0
1.7
|
L
 -35.9%
H
0.6
1.9
|
L
H
0.6
13.5
|
L
H
0.6
13.5
|
| Pulmonx Corp |
|
55.3
|
1.3
|
L
 -2.2%
H
1.3
1.3
|
L
 3.2%
H
1.2
1.4
|
L
 -7.8%
H
1.2
1.6
|
L
 -10.9%
H
1.1
2.2
|
L
 -59.8%
H
1.1
3.9
|
L
 -89.9%
H
1.1
14.8
|
L
 -96.5%
H
1.1
45.8
|
L
H
1.1
69.5
|
| Masimo Corp |
|
9,341.6
|
178.4
|
L
 0.0%
H
178.4
178.5
|
L
 -0.1%
H
178.3
178.8
|
L
 0.0%
H
178.2
178.8
|
L
 37.1%
H
174.4
179
|
L
 16.5%
H
125.9
179
|
L
 3.3%
H
75.2
194.9
|
L
 -18.9%
H
75.2
305.2
|
L
 280.6%
H
46.9
305.2
|
| 908 Devices Inc |
|
263.2
|
7.0
|
L
 -4.7%
H
6.9
7.4
|
L
 -13.9%
H
6.9
8.4
|
L
 -4.9%
H
6.4
8.4
|
L
 7.2%
H
5.7
8.4
|
L
 61.1%
H
4.2
9.3
|
L
 -7.0%
H
1.8
12.5
|
L
 -81.1%
H
1.8
45.1
|
L
H
1.8
79.6
|
| Mimedx Grp Inc |
|
521.3
|
3.5
|
L
 -1.4%
H
3.5
3.6
|
L
 -5.2%
H
3.5
3.7
|
L
 -10.7%
H
3.0
4.0
|
L
 -31.6%
H
3.0
5.5
|
L
 -49.7%
H
3.0
8.0
|
L
 -43.0%
H
3.0
10.1
|
L
 -63.0%
H
2.4
16.0
|
L
 -48.1%
H
1.0
18.3
|
| Mesa Laboratories Inc |
|
550.8
|
99.7
|
L
 -0.8%
H
99.5
100.5
|
L
 -6.1%
H
98.1
105.9
|
L
 0.7%
H
92.7
109.5
|
L
 10.1%
H
71.1
109.5
|
L
 -17.0%
H
55.5
123.3
|
L
 -36.2%
H
55.5
162.8
|
L
 -59.6%
H
55.5
333.4
|
L
 -7.5%
H
55.5
333.4
|
| Merit Medical Systems Inc |
|
3,693.2
|
61.9
|
L
 -1.0%
H
61.5
63.2
|
L
 -0.7%
H
59.7
64.1
|
L
 -12.2%
H
59.7
71.9
|
L
 -24.2%
H
59.7
84.0
|
L
 -36.2%
H
59.7
100.1
|
L
 -26.3%
H
59.7
111.5
|
L
 3.7%
H
50.5
111.5
|
L
 235.0%
H
18.2
111.5
|
| Modular Medical Inc |
|
19.8
|
3.7
|
L
 5.5%
H
3.6
3.7
|
L
 -7.6%
H
3.3
4.1
|
L
 -24.1%
H
3.3
5.9
|
L
 -73.1%
H
3.3
16.2
|
L
 -87.5%
H
3.3
30.6
|
L
 -91.0%
H
3.3
79.5
|
L
 -99.1%
H
3.3
585.0
|
L
 -85.0%
H
3.3
585.0
|
| Myriad Genetics Inc |
|
341.9
|
3.6
|
L
H
3.6
3.8
|
L
 -11.5%
H
3.6
4.4
|
L
 -26.3%
H
3.6
5.4
|
L
 -19.4%
H
3.6
5.7
|
L
 -5.7%
H
3.6
8.6
|
L
 -79.7%
H
3.6
29.3
|
L
 -86.8%
H
3.6
37.0
|
L
 -89.6%
H
3.6
50.4
|
| MDxHealth SA (ADR) |
|
-
|
0.8
|
L
 -14.3%
H
0.7
1.0
|
L
 -58.2%
H
0.7
2.1
|
L
 -63%
H
0.7
2.4
|
L
 -75.3%
H
0.7
3.8
|
L
 -52.8%
H
0.7
5.3
|
L
 -77.4%
H
0.7
5.3
|
L
H
0.7
13.2
|
L
H
0.7
13.2
|
| ENvue Medical Inc |
|
4.1
|
1.1
|
L
 -0.9%
H
1.1
1.1
|
L
 -15.2%
H
1.1
1.5
|
L
 -28.7%
H
1.1
1.8
|
L
 -60.4%
H
1.1
3.1
|
L
 -97.1%
H
0.7
17.4
|
L
 -99.7%
H
0.7
477.4
|
L
 -99.9%
H
0.7
9218
|
L
 -100.0%
H
0.7
18700
|
| ENDRA Life Sciences Inc |
|
7.3
|
5.9
|
L
 2.8%
H
5.7
6.1
|
L
 19.2%
H
5.0
6.1
|
L
 19.0%
H
4.6
6.7
|
L
 68.1%
H
3.0
6.7
|
L
 88.5%
H
2.9
12.0
|
L
 -91.6%
H
0.0
139.5
|
L
 -99.7%
H
0.0
2440
|
L
H
0.0
5880
|
| Neogen Corp |
|
1,808.9
|
8.3
|
L
 -1.4%
H
8.3
8.4
|
L
 -10.2%
H
8.3
9.3
|
L
 -13.5%
H
8.3
9.9
|
L
 -24.0%
H
8.2
11.4
|
L
 30.3%
H
4.5
11.4
|
L
 -49.8%
H
3.9
24.1
|
L
 -82.1%
H
3.9
47.8
|
L
 -53.1%
H
3.9
48.9
|
| Nephros Inc |
|
34.7
|
3.2
|
L
 -4.2%
H
3.2
3.3
|
L
 -0.9%
H
2.9
3.8
|
L
 11.1%
H
2.7
3.8
|
L
 -22.0%
H
2.7
4.3
|
L
 53.1%
H
2.1
6.4
|
L
 125.4%
H
1.1
6.4
|
L
 -58.2%
H
0.9
11.7
|
L
 13.1%
H
0.9
11.7
|
| NeuroOne Medical Tech Corp |
|
39.7
|
4.6
|
L
H
4.2
4.6
|
L
 1.3%
H
4.2
4.9
|
L
 5.0%
H
4.0
5.4
|
L
 -5.7%
H
3.7
5.4
|
L
 16.2%
H
3.3
7.0
|
L
 -41.5%
H
2.4
12
|
L
 -87.9%
H
2.4
47.8
|
L
H
2.4
180
|
| Nano X Imaging Ltd |
|
120.4
|
1.7
|
L
 -2.3%
H
1.7
1.7
|
L
 -1.7%
H
1.6
1.9
|
L
 -30.0%
H
1.6
3.1
|
L
 -24.1%
H
1.6
3.1
|
L
 -69.2%
H
1.6
5.7
|
L
 -91.0%
H
1.6
22.7
|
L
 -92.1%
H
1.6
34.5
|
L
H
1.6
94.8
|
| NeuroPace Inc |
|
524.0
|
15.4
|
L
 -2.7%
H
15.4
15.6
|
L
 -20.3%
H
13.7
19.6
|
L
 0.1%
H
13.7
19.6
|
L
 2.1%
H
12.5
19.6
|
L
 -1.5%
H
7.6
19.6
|
L
 260.8%
H
3.8
19.6
|
L
 -26.5%
H
1.2
26.3
|
L
H
1.2
27.4
|
| InspireMD Inc |
|
53.5
|
1.1
|
L
H
1.1
1.1
|
L
 -1.7%
H
1.1
1.3
|
L
 -15.6%
H
1.0
1.4
|
L
 -34.9%
H
1.0
2.0
|
L
 -51.7%
H
1.0
2.9
|
L
 -21.4%
H
1.0
3.9
|
L
 -75.2%
H
0.8
6.8
|
L
 -100.0%
H
0.8
314868.8
|
| Nortech Systems Inc |
|
32.9
|
11.8
|
L
 -2.6%
H
11.8
12
|
L
 -5.8%
H
11.8
14.2
|
L
 -16.6%
H
11.8
15.4
|
L
 25.4%
H
8.5
15.4
|
L
 34.7%
H
6.5
15.4
|
L
 25.8%
H
6.5
19.2
|
L
 104.0%
H
5.6
19.6
|
L
 210.3%
H
1.7
19.6
|
| Natera Inc |
|
27,481.6
|
191.9
|
L
 -2.6%
H
190
198.7
|
L
 -12.7%
H
190
217.6
|
L
 -10.6%
H
189.5
221.6
|
L
 -7.0%
H
181
221.6
|
L
 26.8%
H
131.8
256.4
|
L
 275.5%
H
36.9
256.4
|
L
 105.9%
H
26.1
256.4
|
L
 1592.2%
H
7.4
256.4
|
| Nutriband Inc |
|
42.7
|
3.5
|
L
 -2.2%
H
3.5
3.5
|
L
 -7.4%
H
3.5
3.9
|
L
 -13.6%
H
3.5
4.3
|
L
 -14.6%
H
3.4
4.5
|
L
 -37.8%
H
3.4
11.7
|
L
 7.7%
H
1.5
11.8
|
L
 -78.2%
H
0.9
16.1
|
L
H
0.9
43.5
|
| Nuwellis Inc |
|
2.8
|
1.1
|
L
 4.9%
H
1.0
1.1
|
L
 -2.7%
H
1.0
1.1
|
L
 -13.0%
H
1.0
1.2
|
L
 -45.7%
H
1.0
2.0
|
L
 -97.4%
H
1.0
43.2
|
L
 -100.0%
H
1.0
5630.1
|
L
 -100.0%
H
1.0
792330
|
L
 -100.0%
H
1.0
10000000000
|
| NovoCure Ltd |
|
2,091.7
|
18.1
|
L
 0.1%
H
17.8
18.2
|
L
 7.3%
H
16.9
18.9
|
L
 59.8%
H
11.3
18.9
|
L
 64.3%
H
10.1
18.9
|
L
 5.6%
H
9.8
20.1
|
L
 -75.9%
H
9.8
83.6
|
L
 -89.9%
H
9.8
232.8
|
L
 47.2%
H
6.0
232.8
|
| enVVeno Medical Corp |
|
6.0
|
9.0
|
L
 -12.2%
H
9.0
10
|
L
 -11.6%
H
9.0
10.3
|
L
 -17.8%
H
9.0
13.4
|
L
 -3%
H
8.7
13.4
|
L
 -92.9%
H
8.7
196.7
|
L
 -94.3%
H
8.7
244.0
|
L
 -95.0%
H
8.7
398.3
|
L
H
8.7
4935
|
| Nexalin Tech Inc |
|
7.0
|
0.3
|
L
H
0.3
0.3
|
L
H
0.3
0.4
|
L
 -20.9%
H
0.3
0.5
|
L
 -24.4%
H
0.3
0.7
|
L
 -72.1%
H
0.3
2
|
L
 -60%
H
0.3
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
| Nyxoah SA |
|
134.5
|
3.1
|
L
 5.5%
H
3.0
3.1
|
L
 -3.8%
H
2.9
3.4
|
L
 -5.8%
H
2.9
3.4
|
L
 -30.5%
H
2.8
5.2
|
L
 -49.2%
H
2.8
8.6
|
L
 -61.3%
H
2.8
20
|
L
 -86.7%
H
2.8
37
|
L
H
2.8
37
|
| Nanobiotix (ADR) |
|
2,473.3
|
51
|
L
 -7.4%
H
51
54.0
|
L
 19.7%
H
40.7
57.1
|
L
 60.2%
H
30.2
57.1
|
L
 101.3%
H
24.5
57.1
|
L
 1214.4%
H
3.6
57.1
|
L
 953.7%
H
2.8
57.1
|
L
 229.7%
H
1.8
57.1
|
L
H
1.8
57.1
|
| Orchestra BioMed Holdings Inc |
|
237.7
|
4.0
|
L
 -3.4%
H
4.0
4.1
|
L
 1.0%
H
3.8
4.1
|
L
 -12.0%
H
3.8
4.7
|
L
 3.7%
H
3.8
4.9
|
L
 40.8%
H
2.2
5.4
|
L
 -76.6%
H
2.2
20.2
|
L
 -61.5%
H
2.2
23.4
|
L
H
2.2
23.4
|
| Orthofix Medical Inc |
|
483.0
|
12.0
|
L
 -2.8%
H
12.0
12.2
|
L
 -1.0%
H
11.5
12.6
|
L
 -6.1%
H
11.3
13.0
|
L
 -10.7%
H
11.1
14.2
|
L
 -0.2%
H
10.2
17.0
|
L
 -34.3%
H
9.6
21.6
|
L
 -71.9%
H
9.6
43.3
|
L
 -72.2%
H
9.6
74.4
|
| Outset Medical Inc |
|
68.6
|
3.7
|
L
 -2.9%
H
3.7
3.8
|
L
 -20.9%
H
3.5
4.1
|
L
 -14.9%
H
3.5
4.8
|
L
 9.1%
H
3
4.8
|
L
 -80%
H
3
22.0
|
L
 -98.8%
H
0.5
362.0
|
L
 -99.4%
H
0.5
905.0
|
L
H
0.5
1004.4
|
| Organogenesis Holdings Inc (Class A) |
|
328.1
|
2.6
|
L
 -1.5%
H
2.5
2.6
|
L
 0.8%
H
2.0
2.8
|
L
 1.6%
H
2.0
2.8
|
L
 -31.6%
H
2.0
4.1
|
L
 -15.3%
H
2.0
7.1
|
L
 -17.7%
H
2.0
7.1
|
L
 -86.4%
H
1.8
19.8
|
L
H
1.8
310.9
|
| Orasure Tech Inc |
|
205.9
|
3.0
|
L
 1.4%
H
3.0
3.0
|
L
 -4.5%
H
2.9
3.1
|
L
 -6.9%
H
2.9
3.3
|
L
 8.7%
H
2.5
3.5
|
L
 20.1%
H
2.1
3.8
|
L
 -50.2%
H
2.1
8.5
|
L
 -68.6%
H
2.1
13.6
|
L
 -55.2%
H
2.1
23.0
|
| Pacific Biosciences of California Inc |
|
360.3
|
1.2
|
L
 -4.1%
H
1.2
1.2
|
L
 -29.7%
H
1.2
1.5
|
L
 -26.1%
H
1.2
1.8
|
L
 -32.2%
H
1.2
1.8
|
L
 5.5%
H
0.9
2.7
|
L
 -90.5%
H
0.9
14.6
|
L
 -95.1%
H
0.9
36.4
|
L
 -86.8%
H
0.9
53.7
|
| PAVmed Inc |
|
46.5
|
6.4
|
L
 -0.8%
H
6.4
6.4
|
L
 -10.4%
H
6.3
7.4
|
L
 -30.1%
H
6.3
9.5
|
L
 -38.8%
H
6.3
11.0
|
L
 -70.8%
H
6
28.4
|
L
 -97.3%
H
6
270
|
L
 -99.6%
H
6
4365
|
L
H
6
6858
|
| Pro-Dex Inc (co) |
|
184.3
|
57.7
|
L
 -1.6%
H
57.7
57.7
|
L
 0.5%
H
56.2
61.6
|
L
 9.4%
H
43.3
61.6
|
L
 46.2%
H
38.3
61.6
|
L
 33.2%
H
23.5
61.6
|
L
 262.4%
H
14.5
70.3
|
L
 64.9%
H
12.4
70.3
|
L
 1261.6%
H
3.7
70.3
|
| Pulse Biosciences Inc |
|
1,779.8
|
26.0
|
L
 -3.9%
H
25.5
26.8
|
L
 32.9%
H
18.7
28.0
|
L
 29.4%
H
18.4
28.0
|
L
 13.2%
H
17.5
28.0
|
L
 59.8%
H
12.6
28.0
|
L
 221.9%
H
3.8
28.0
|
L
 49.2%
H
1.2
29.2
|
L
H
1.2
45.8
|
| Axe Compute Inc |
|
30.1
|
5.4
|
L
 -3.0%
H
5.4
5.7
|
L
 -9.1%
H
5.3
6.8
|
L
 56.5%
H
3.1
10.9
|
L
 122.5%
H
1.0
10.9
|
L
 -66.2%
H
1.0
32.1
|
L
 -90.4%
H
1.0
106.8
|
L
 -97.9%
H
1.0
492
|
L
 -100.0%
H
1.0
20250
|
| Precision Optics Corp Inc |
|
53.5
|
4.9
|
L
 2.3%
H
4.5
4.9
|
L
 3.0%
H
4.3
5.1
|
L
 13.5%
H
4.0
5.1
|
L
 2.7%
H
3.6
5.3
|
L
 5.8%
H
3.6
6.0
|
L
 -19.8%
H
3.5
7.0
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
| Insulet |
|
10,492.9
|
151.5
|
L
 1.9%
H
149.9
152.7
|
L
 -5.6%
H
145.6
164.7
|
L
 -24.8%
H
145.6
206.0
|
L
 -37.6%
H
145.6
275.1
|
L
 -52.9%
H
145.6
354.9
|
L
 -54.1%
H
125.8
354.9
|
L
 -34.8%
H
125.8
354.9
|
L
 463.4%
H
26.6
354.9
|
| Procept BioRobotics Corp |
|
1,496.4
|
26.3
|
L
 -0.3%
H
25.8
26.7
|
L
 3.3%
H
24.5
29.1
|
L
 6.9%
H
21.3
29.1
|
L
 -5.4%
H
19.4
29.1
|
L
 -52%
H
19.4
66.9
|
L
 -12.9%
H
19.4
103.8
|
L
H
15.4
103.8
|
L
H
15.4
103.8
|
| Prenetics Global Ltd (Class A) |
|
289.5
|
17.0
|
L
 -3.2%
H
17.0
17.7
|
L
 7.3%
H
15.3
18.3
|
L
 -5.4%
H
15.1
20.2
|
L
 -22.5%
H
14.6
23.6
|
L
 193.6%
H
5.6
23.6
|
L
 8.1%
H
2.9
23.6
|
L
H
2.9
131.3
|
L
H
2.9
131.3
|
| Profound Medical Corp |
|
258.0
|
7.1
|
L
 -1.4%
H
7.1
7.2
|
L
 -0.8%
H
6.8
7.9
|
L
 13.4%
H
6.2
7.9
|
L
 7.6%
H
4.8
8.0
|
L
 75.7%
H
3.8
9.0
|
L
 -48.7%
H
3.8
15.5
|
L
 -57.9%
H
3.1
19.3
|
L
H
0.0
29.0
|
| QuidelOrtho Corporation |
|
752.1
|
11.0
|
L
 -3.2%
H
10.9
11.5
|
L
 2.4%
H
9.9
11.7
|
L
 -36.3%
H
9.9
18
|
L
 -53.2%
H
9.9
24.8
|
L
 -67.1%
H
9.9
35.6
|
L
 -87.4%
H
9.9
90.5
|
L
 -90.7%
H
9.9
180.1
|
L
 -28.7%
H
9.9
306.7
|
| Quanterix Corp |
|
127.7
|
2.7
|
L
 -2.2%
H
2.7
2.8
|
L
 -1.5%
H
2.6
3.1
|
L
 -20.1%
H
2.6
3.7
|
L
 -52.8%
H
2.6
6.8
|
L
 -36.7%
H
2.6
8.8
|
L
 -83.2%
H
2.6
29.7
|
L
 -94.1%
H
2.6
69.2
|
L
H
2.6
92.6
|
| AVITA Medical Inc |
|
156.3
|
5.1
|
L
 16.5%
H
4.7
5.5
|
L
 21.5%
H
4.0
5.5
|
L
 -9.3%
H
4.0
5.7
|
L
 22.1%
H
3.5
5.9
|
L
 -24.1%
H
3.2
7.1
|
L
 -58.1%
H
3.2
21.7
|
L
 -75.3%
H
3.2
22.5
|
L
 -48.9%
H
3.2
55.4
|
| Rockwell Medical Inc |
|
30.8
|
0.8
|
L
 -2.5%
H
0.8
0.8
|
L
H
0.8
0.9
|
L
 -16.1%
H
0.7
0.9
|
L
 -22.8%
H
0.7
1.1
|
L
 -22.8%
H
0.7
2.1
|
L
 -68.2%
H
0.7
6.2
|
L
 -92.2%
H
0.7
11.7
|
L
 -99.2%
H
0.7
116.4
|
| Vyome Holdings Inc |
|
13.1
|
1.9
|
L
 -3.1%
H
1.9
1.9
|
L
 -11.4%
H
1.9
2.3
|
L
 -18.4%
H
1.9
2.4
|
L
 -28.2%
H
1.9
3.5
|
L
 -69.3%
H
1.8
12.9
|
L
 -98.7%
H
0.3
160.1
|
L
 -100.0%
H
0.3
42456
|
L
H
0.3
1381560
|
| Rewalk Robotics Ltd |
|
396.7
|
6.6
|
L
 -0.5%
H
6.1
6.8
|
L
 -2.4%
H
6.1
7
|
L
 -0.5%
H
6.1
7.7
|
L
 1194.1%
H
0.4
7.7
|
L
 407.7%
H
0.4
7.7
|
L
 54.2%
H
0.4
9.1
|
L
 -44.2%
H
0.4
19.5
|
L
 -99.6%
H
0.4
1732.5
|
| Sanmina Corp |
|
12,488.3
|
233
|
L
 -3.7%
H
228.4
235
|
L
 -1.7%
H
226.0
255.2
|
L
 50.8%
H
151.4
255.2
|
L
 59.8%
H
118.1
255.2
|
L
 175.0%
H
78.4
255.2
|
L
 361.4%
H
43.4
255.2
|
L
 450.2%
H
35.1
255.2
|
L
 838.4%
H
18.3
255.2
|
| Sight Sciences Inc |
|
278.6
|
5.1
|
L
 -1.5%
H
5.1
5.2
|
L
 -3.2%
H
4.7
5.7
|
L
 34.0%
H
3.8
5.7
|
L
 -4.5%
H
3.4
5.7
|
L
 56.1%
H
3.1
9.2
|
L
 -48.4%
H
1.0
10.7
|
L
H
1.0
42.6
|
L
H
1.0
42.6
|
| Sotera Health Co |
|
4,383.0
|
15.4
|
L
 -0.8%
H
15.3
15.4
|
L
 -1.9%
H
15.2
15.9
|
L
 -3.5%
H
14.3
16.5
|
L
 -10.2%
H
13.1
17.9
|
L
 20.0%
H
10.8
19.9
|
L
 4.7%
H
9.5
19.9
|
L
 -31.7%
H
5.8
27.4
|
L
H
5.8
30.4
|
| SI-BONE Inc |
|
628.9
|
14.2
|
L
 -2.9%
H
14.1
14.6
|
L
 9.5%
H
11.5
14.9
|
L
 -1.7%
H
11.5
14.9
|
L
 -7.5%
H
11.5
16.9
|
L
 -24.4%
H
11.5
21.9
|
L
 -42.1%
H
11.5
29.5
|
L
 -55.6%
H
11.1
34.4
|
L
H
7.2
37.2
|
| SINTX Tech Inc |
|
9.6
|
2.3
|
L
 -2.9%
H
2.3
2.4
|
L
 -2.5%
H
2.3
2.6
|
L
 -16.8%
H
2.0
2.9
|
L
 -23.4%
H
2.0
3.2
|
L
 -32.5%
H
2.0
6.8
|
L
 -99.2%
H
0.1
364
|
L
 -100.0%
H
0.1
41100
|
L
 -100.0%
H
0.1
11664000
|
| Beauty Health Co (Class A) |
|
84.2
|
0.7
|
L
 -4.4%
H
0.7
0.7
|
L
 -28.6%
H
0.6
0.8
|
L
 -34.3%
H
0.6
1
|
L
 -37.5%
H
0.6
1.4
|
L
 -56.1%
H
0.6
2.7
|
L
 -93.8%
H
0.6
11.0
|
L
 -95.2%
H
0.6
30.2
|
L
H
0.6
30.2
|
| Sanara MedTech Inc |
|
196.4
|
21.4
|
L
 -1.0%
H
21.0
21.6
|
L
 12.3%
H
17.8
24.3
|
L
 15.8%
H
17.8
24.3
|
L
 13.3%
H
16.1
24.3
|
L
 -31.5%
H
16.1
36.0
|
L
 -47.8%
H
16.1
46.4
|
L
 -8.1%
H
16.1
50.2
|
L
 245.6%
H
2
75
|
| Sensus Healthcare Inc |
|
56.5
|
3.4
|
L
 -5.0%
H
3.4
3.7
|
L
 -16.6%
H
2.8
3.7
|
L
 -23.6%
H
2.8
4.6
|
L
 -11.1%
H
2.8
4.9
|
L
 -28.8%
H
2.8
5.9
|
L
 20.8%
H
1.8
9.3
|
L
 5.9%
H
1.8
15.3
|
L
H
1.8
15.3
|
| Staar Surgical Co. |
|
1,568.3
|
31.5
|
L
 -1.6%
H
31.5
32.4
|
L
 15.5%
H
26.4
35.9
|
L
 28.9%
H
23.6
35.9
|
L
 95.7%
H
15.6
35.9
|
L
 80.7%
H
15.6
35.9
|
L
 -49.7%
H
13.5
65.1
|
L
 -71.5%
H
13.5
163.1
|
L
 481.2%
H
5.0
163.1
|
| Neuronetics Inc |
|
89.1
|
1.3
|
L
 -1.5%
H
1.3
1.3
|
L
 -30.4%
H
1.3
1.8
|
L
 -10.5%
H
1.3
2.5
|
L
 -9.9%
H
0.8
2.5
|
L
 -70.2%
H
0.8
4.9
|
L
 -54.0%
H
0.5
5.9
|
L
 -90.0%
H
0.5
17.9
|
L
H
0.5
39.4
|
| Star Equity Holdings Inc |
|
32.3
|
10
|
L
 0.4%
H
10.0
10
|
L
 8.1%
H
9
10
|
L
 3.0%
H
9
10.3
|
L
 -1.4%
H
9.0
11
|
L
 325.5%
H
1.8
12.0
|
L
 136.4%
H
1.7
12.0
|
L
 -22.8%
H
1.7
23.4
|
L
 -96.2%
H
1.7
307.5
|
| Sharps Tech Inc |
|
74.2
|
1.9
|
L
 -4%
H
1.9
2.0
|
L
 2.7%
H
1.9
2.1
|
L
 10.3%
H
1.7
2.1
|
L
 9.1%
H
1.4
2.1
|
L
 -57.9%
H
1.4
18.2
|
L
 -100.0%
H
0.0
7590
|
L
H
0.0
23892
|
L
H
0.0
23892
|
| Tactile Systems Tech Inc |
|
515.4
|
22.9
|
L
 -0.8%
H
22.5
23.1
|
L
 -12.2%
H
22.5
26.3
|
L
 -8.8%
H
20.5
27.6
|
L
 -13.6%
H
20.5
37.8
|
L
 138.5%
H
9.3
37.8
|
L
 6.0%
H
8.6
37.8
|
L
 -58.1%
H
6.3
57.6
|
L
H
6.3
76.6
|
| TELA Bio Inc |
|
42.5
|
1.0
|
L
 -4.0%
H
0.9
1.0
|
L
 -13.6%
H
0.9
1.2
|
L
 58.3%
H
0.6
1.3
|
L
 20.3%
H
0.5
1.3
|
L
 -4.0%
H
0.5
2.2
|
L
 -90.1%
H
0.5
11.3
|
L
 -92.4%
H
0.5
16.5
|
L
H
0.5
23.5
|
| Valion Bio Inc |
|
3.1
|
1.0
|
L
 5.4%
H
0.9
1.1
|
L
 -5.8%
H
0.9
1.2
|
L
 5.4%
H
0.9
1.4
|
L
 19.5%
H
0.7
1.4
|
L
 -77.3%
H
0.7
5.6
|
L
 -99.7%
H
0.7
369.8
|
L
H
0.7
11050
|
L
H
0.7
11050
|
| Treace Medical Concepts Inc |
|
188.8
|
2.9
|
L
 5.1%
H
2.8
2.9
|
L
 51.6%
H
1.8
2.9
|
L
 36.6%
H
1.7
2.9
|
L
 56.5%
H
1.2
2.9
|
L
 -56.7%
H
1.2
7.8
|
L
 -88.4%
H
1.2
27.7
|
L
 -90.1%
H
1.2
37.2
|
L
H
1.2
37.2
|
| Transmedics Grp Inc |
|
2,194.6
|
63.5
|
L
 2.4%
H
61.4
63.8
|
L
 -12.9%
H
60.1
72.7
|
L
 -45.1%
H
60.1
120.9
|
L
 -51.1%
H
60.1
151
|
L
 -48.1%
H
60.1
156
|
L
 -16.1%
H
36.4
177.4
|
L
 185.5%
H
10
177.4
|
L
H
10
177.4
|
| Tandem Diabetes Care Inc |
|
888.1
|
13.0
|
L
 -8.4%
H
12.9
13.7
|
L
 -29.8%
H
12.9
20.0
|
L
 -38.6%
H
12.9
22.0
|
L
 -31.6%
H
12.9
29.7
|
L
 -43.3%
H
10.0
29.7
|
L
 -60.7%
H
10.0
53.7
|
L
 -83.6%
H
10.0
155.9
|
L
 -80.8%
H
2.1
155.9
|
| Trinity Biotech PLC (ADR) |
|
11.7
|
0.6
|
L
H
0.6
0.6
|
L
 -1.7%
H
0.6
0.6
|
L
 -19.4%
H
0.6
0.8
|
L
 -24.7%
H
0.5
0.8
|
L
 -97.1%
H
0.5
86
|
L
 -99.9%
H
0.5
687.5
|
L
 -100.0%
H
0.5
2337.5
|
L
 -100.0%
H
0.5
8550
|
| Utah Medical Products Inc |
|
201.4
|
63.2
|
L
 -0.7%
H
63.2
63.2
|
L
 -3.3%
H
62.5
66.0
|
L
 -7.5%
H
62.5
71.8
|
L
 -1.3%
H
60.9
71.8
|
L
 16.3%
H
52
71.8
|
L
 -31.0%
H
51.3
100.6
|
L
 -28.5%
H
51.3
133.9
|
L
 -2.8%
H
51.3
133.9
|
| Vivani Medical Inc |
|
101.8
|
1.2
|
L
 -1.7%
H
1.2
1.2
|
L
 -2.5%
H
1.1
1.2
|
L
 10.3%
H
1.1
1.5
|
L
H
0.9
1.5
|
L
 16.8%
H
0.9
1.9
|
L
 -14.5%
H
0.8
7.8
|
L
 -92.3%
H
0.8
22.9
|
L
 -98.8%
H
0.8
114
|
| Veracyte Inc |
|
3,072.0
|
38.5
|
L
 -1.0%
H
37.7
38.7
|
L
 -5.5%
H
37.7
41.0
|
L
 12.2%
H
31.2
42.1
|
L
 7.6%
H
29.5
42.1
|
L
 35.1%
H
22.6
50.7
|
L
 63.7%
H
18.6
50.7
|
L
 5.3%
H
14.9
54.1
|
L
 646.1%
H
4.8
86.0
|
| Varex Imaging Corp |
|
416.0
|
9.9
|
L
 -1.5%
H
9.9
10.0
|
L
 -16.6%
H
9.1
11.4
|
L
 -15.9%
H
9.1
12.8
|
L
 -27%
H
9.1
13.9
|
L
 32.5%
H
6.8
14.6
|
L
 -55.6%
H
6.8
23.9
|
L
 -58.8%
H
6.8
32.7
|
L
H
6.8
43.8
|
| Vivos Therapeutics Inc |
|
9.2
|
0.7
|
L
 -2.9%
H
0.7
0.7
|
L
 1.5%
H
0.7
0.8
|
L
 -50.4%
H
0.7
1.5
|
L
 -55.9%
H
0.7
1.7
|
L
 -78.0%
H
0.7
8.0
|
L
 -91.8%
H
0.7
48.8
|
L
 -99.6%
H
0.7
177.3
|
L
H
0.7
360.3
|
| Wrap Tech Inc |
|
88.6
|
1.6
|
L
 -3.6%
H
1.6
1.6
|
L
 10.4%
H
1.4
1.7
|
L
 3.9%
H
1.4
1.7
|
L
 -11.2%
H
1.4
1.8
|
L
 6%
H
1.2
3.2
|
L
 34.7%
H
1.0
7.0
|
L
 -73.0%
H
1.0
9.8
|
L
H
1.0
14.4
|
| Beyond Air Inc |
|
6.3
|
0.5
|
L
 6.4%
H
0.5
0.5
|
L
H
0.4
0.6
|
L
 -12.3%
H
0.4
0.6
|
L
 -52.4%
H
0.4
1.2
|
L
 -86.5%
H
0.4
5.8
|
L
 -99.6%
H
0.4
127.2
|
L
 -99.5%
H
0.4
328.2
|
L
H
0.4
900
|
| DENTSPLY Sirona Inc |
|
1,985.2
|
9.9
|
L
 -4.8%
H
9.9
10.4
|
L
 -9.6%
H
9.9
11.3
|
L
 -18.9%
H
9.9
13.0
|
L
 -23.5%
H
9.9
14.8
|
L
 -39.8%
H
9.9
17.1
|
L
 -75.8%
H
9.9
41.6
|
L
 -85.4%
H
9.9
69.1
|
L
 -83.8%
H
9.9
69.5
|
| X.T.L. Biopharma Ltd (ADR) |
|
6.1
|
2.6
|
L
 -4.4%
H
2.6
2.6
|
L
 -3.4%
H
2.5
2.9
|
L
 5.7%
H
2.3
4.9
|
L
 -27.5%
H
2.2
4.9
|
L
 -87%
H
2.1
41.1
|
L
 -86.7%
H
2.1
79.8
|
L
 -95.2%
H
2.1
107.0
|
L
 -96.3%
H
2.1
125.6
|
| 111 Inc (ADR) |
|
52.8
|
6
|
L
H
5.9
6.1
|
L
 7.5%
H
5.6
6.4
|
L
 -11.9%
H
5.3
7.2
|
L
 -25.9%
H
5.3
8.5
|
L
 -21.2%
H
2.5
11.2
|
L
 120.6%
H
0.4
11.3
|
L
 -42.3%
H
0.4
12
|
L
H
0.4
45.9
|
| Jin Medical Intl Ltd |
|
19.3
|
2.5
|
L
H
2.4
2.6
|
L
 11.8%
H
2.1
2.7
|
L
 15.5%
H
1.9
2.7
|
L
 -12.1%
H
1.6
3.2
|
L
 -80.7%
H
1.6
17.2
|
L
 -55.8%
H
1.6
509.9
|
L
H
1.6
509.9
|
L
H
1.6
509.9
|
| HeartBeam Inc |
|
56.1
|
1.0
|
L
 -2.9%
H
1
1.0
|
L
 16.1%
H
0.9
1.1
|
L
 -15.8%
H
0.8
1.1
|
L
 -24.1%
H
0.8
1.8
|
L
 -36.9%
H
0.5
4
|
L
 -36.1%
H
0.5
4
|
L
 -36.1%
H
0.5
4
|
L
 -36.1%
H
0.5
4
|
| Cencora |
|
51,296.0
|
263.7
|
L
 1.0%
H
260.1
263.7
|
L
 3.1%
H
251.6
266.4
|
L
 -17.6%
H
244.8
328.0
|
L
 -26.9%
H
244.8
376.9
|
L
 -5.6%
H
244.8
377.5
|
L
 54.2%
H
163.4
377.5
|
L
 126.3%
H
111.3
377.5
|
L
 257.9%
H
68.4
377.5
|
| Incannex Healthcare Ltd (ADR) |
|
54.2
|
3.9
|
L
H
3.9
4
|
L
 -19.2%
H
3.7
5.0
|
L
 9.6%
H
3.4
5
|
L
 -51.9%
H
2.5
9.3
|
L
 -81.5%
H
2.5
49.8
|
L
 -97.6%
H
2.4
160.2
|
L
 -97.6%
H
2.4
160.2
|
L
 -97.6%
H
2.4
160.2
|
| Rewalk Robotics Ltd |
|
18.0
|
6.5
|
L
 -1.8%
H
6.1
6.7
|
L
 -4.1%
H
6.1
7
|
L
 -2.3%
H
6.1
7.7
|
L
 5.9%
H
4.1
7.7
|
L
 -62.5%
H
4.1
17.6
|
L
 -87.4%
H
4.1
109.2
|
L
 -95.4%
H
4.1
233.5
|
L
 -100.0%
H
4.1
20790
|
| Work Medical Tech Grp Ltd |
|
1.2
|
1.0
|
L
 -26.9%
H
0.9
1.1
|
L
 -27.5%
H
0.2
7.3
|
L
 -18.1%
H
0.2
7.3
|
L
 -37.5%
H
0.2
7.3
|
L
 -100.0%
H
0.2
10800
|
L
H
0.2
84460
|
L
H
0.2
84460
|
L
H
0.2
84460
|
| iTonic Holdings Ordinary |
|
5.3
|
0.3
|
L
H
0.3
0.3
|
L
 -8.8%
H
0.3
0.3
|
L
 10.7%
H
0.3
0.4
|
L
 -24.4%
H
0.3
0.5
|
L
 -93.8%
H
0.3
32
|
L
H
0.3
32
|
L
H
0.3
32
|
L
H
0.3
32
|
| Ceribell Inc |
|
629.5
|
16.6
|
L
 0.8%
H
16.4
16.9
|
L
 -18.6%
H
15.8
20.6
|
L
 -15.1%
H
15.8
21.7
|
L
 -16.1%
H
15.8
21.7
|
L
 0.8%
H
10.9
24.3
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
| Anteris Tech Global Corp |
|
692.1
|
7.1
|
L
 -1.9%
H
6.9
7.2
|
L
 9.2%
H
6.3
7.5
|
L
 13.0%
H
5.4
7.5
|
L
 24.5%
H
5.0
7.5
|
L
 73.4%
H
2.9
7.5
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
| Beta Bionics Inc |
|
406.4
|
9.1
|
L
 -0.9%
H
9.0
9.2
|
L
 -13.1%
H
9.0
10.5
|
L
 -22.8%
H
9.0
13.4
|
L
 -34.6%
H
8.8
14.4
|
L
 -29.0%
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
| Wellgistics Health Inc |
|
11.4
|
0.1
|
L
H
0.1
0.1
|
L
H
0.1
0.1
|
L
 -35.7%
H
0.1
0.2
|
L
 -67.9%
H
0.1
0.3
|
L
 -95.0%
H
0.1
3
|
L
H
0.1
7.0
|
L
H
0.1
7.0
|
L
H
0.1
7.0
|
| Kestra Medical Tech Ltd |
|
1,261.4
|
21.6
|
L
 -2.1%
H
21.0
21.8
|
L
 0.4%
H
19
22.4
|
L
 9.5%
H
19
24.5
|
L
 -19.7%
H
17.3
27.4
|
L
 -3.5%
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
| Sanuwave Health Inc |
|
146.4
|
17.0
|
L
 -0.3%
H
17.0
17.2
|
L
 2.2%
H
15.4
20.1
|
L
 -2.8%
H
15.4
21.2
|
L
 -31.6%
H
15.4
25.6
|
L
 -47.3%
H
15.4
46.6
|
L
 -47.3%
H
15.4
46.6
|
L
 -47.3%
H
15.4
46.6
|
L
 -47.3%
H
15.4
46.6
|
| SS Innovations Intl Inc |
|
804.5
|
4.0
|
L
 0.8%
H
4.0
4.1
|
L
 2.3%
H
3.8
4.3
|
L
 -17.8%
H
3.7
5.1
|
L
 -6.7%
H
3.7
5.3
|
L
 -60%
H
3.0
11.9
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
| Medline Inc Ordinary Shares |
|
32,843.3
|
38.8
|
L
 -0.2%
H
38.7
39.4
|
L
 -7.2%
H
37.6
42.2
|
L
 -18.5%
H
37.6
49.1
|
L
 -12.8%
H
37.6
50.9
|
L
 -5.3%
H
37.6
50.9
|
L
 -5.3%
H
37.6
50.9
|
L
 -5.3%
H
37.6
50.9
|
L
 -5.3%
H
37.6
50.9
|